Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
ASTE
Valuation N/A
ASTEC INDUSTRIES INC
Price$38.71
Model IV—
P/IV—
Market implies +24.0%/yr
ASTH
Deeply overvalued
Astrana Health, Inc.
Price$37.55
Model IV$16.75
P/IV2.08
Premium +124%
Return to IV: -55.4%
Market implies +23.2%/yr
vs model +16.9% · above model
ASTL
Valuation N/A
Algoma Steel Group Inc.
Price$4.30
Model IV—
P/IV—
Limited data — see page
ASYS
Valuation N/A
AMTECH SYSTEMS INC
Price$16.45
Model IV—
P/IV—
Market implies +17.6%/yr
ATEC
Deeply undervalued
Alphatec Holdings, Inc.
Price$10.67
Model IV$24.78
P/IV0.40
Discount 57%
Return to IV: +132.2%
Market implies -16.5%/yr
vs model +33.1% · below model
ATEX
Valuation N/A
Anterix Inc.
Price$84.53
Model IV—
P/IV—
Market implies +48.9%/yr
ATHE
Valuation N/A
ALTERITY THERAPEUTICS LTD
Price$3.12
Model IV—
P/IV—
Limited data — see page
ATII
Valuation N/A
Archimedes Tech SPAC Partners II Co.
Price$10.69
Model IV—
P/IV—
Limited data — see page
ATIIU
Valuation N/A
Archimedes Tech SPAC Partners II Co.
Price$11.24
Model IV—
P/IV—
Limited data — see page
ATLC
Deeply undervalued
Atlanticus Holdings Corp
Price$93.73
Model IV$144.96
P/IV0.62
Discount 35%
Return to IV: +54.7%
Market implies +2.0%/yr
vs model +12.0% · below model
ATLCL
Deeply undervalued
Atlanticus Holdings Corp
Price$25.30
Model IV$196.92
P/IV0.13
Discount 87%
Return to IV: +678.3%
Market implies -22.7%/yr
vs model +12.0% · below model
ATLCP
Deeply undervalued
Atlanticus Holdings Corp
Price$23.00
Model IV$196.92
P/IV0.12
Discount 88%
Return to IV: +756.2%
Market implies -24.5%/yr
vs model +12.0% · below model
ATLCZ
Deeply undervalued
Atlanticus Holdings Corp
Price$25.17
Model IV$196.92
P/IV0.13
Discount 87%
Return to IV: +682.4%
Market implies -22.8%/yr
vs model +12.0% · below model
ATNI
Fairly valued
ATN International, Inc.
Price$25.49
Model IV$26.24
P/IV1.13
Discount 3%
Return to IV: +2.9%
Market implies +1.7%/yr
vs model +3.6% · in line
ATS
Deeply overvalued
ATS Corp /ATS
Price$17.65
Model IV$10.62
P/IV1.70
Premium +66%
Return to IV: -39.8%
Market implies +8.5%/yr
vs model +2.0% · above model
AUDC
Deeply overvalued
AUDIOCODES LTD
Price$11.39
Model IV$8.41
P/IV1.32
Premium +35%
Return to IV: -26.2%
Market implies +10.3%/yr
vs model +8.3% · in line
AUNA
Valuation N/A
AUNA S.A.
Price$5.12
Model IV—
P/IV—
Limited data — see page
AURA
Valuation N/A
Aura Biosciences, Inc.
Price$6.54
Model IV—
P/IV—
Limited data — see page
AUTL
Valuation N/A
Autolus Therapeutics plc
Price$1.81
Model IV—
P/IV—
Market implies +24.2%/yr
AVBC
Deeply overvalued
Avidia Bancorp, Inc.
Price$21.89
Model IV$12.32
P/IV1.77
Premium +78%
Return to IV: -43.7%
AVBH
Deeply overvalued
Avidbank Holdings, Inc.
Price$31.05
Model IV$18.93
P/IV1.65
Premium +64%
Return to IV: -39.0%
AVBP
Valuation N/A
ArriVent BioPharma, Inc.
Price$16.73
Model IV—
P/IV—
Limited data — see page
AVEX
Valuation N/A
AEVEX Corp.
Price$14.63
Model IV—
P/IV—
Limited data — see page
AVIR
Valuation N/A
Atea Pharmaceuticals, Inc.
Price$5.15
Model IV—
P/IV—
Market implies -0.3%/yr
AVLN
Valuation N/A
Avalyn Pharma Inc.
Price$25.76
Model IV—
P/IV—
Limited data — see page
AVNS
Valuation N/A
AVNS
Price$24.99
Model IV—
P/IV—
Limited data — see page
AVO
Deeply overvalued
Mission Produce, Inc.
Price$11.74
Model IV$2.83
P/IV4.53
Premium +315%
Return to IV: -75.9%
Market implies +24.7%/yr
vs model +7.0% · above model
AVR
Valuation N/A
Anteris Technologies Global Corp.
Price$6.77
Model IV—
P/IV—
Market implies +87.8%/yr
AVTX
Valuation N/A
Avalo Therapeutics, Inc.
Price$13.65
Model IV—
P/IV—
Market implies +126.0%/yr
AZTA
Valuation N/A
Azenta, Inc.
Price$37.72
Model IV—
P/IV—
Market implies +29.8%/yr
BAK
Valuation N/A
BRASKEM SA
Price$1.82
Model IV—
P/IV—
Market implies -32.4%/yr
vs model +2.1% · below model
BALY
Deeply undervalued
Bally's Corp
Price$13.94
Model IV$48.73
P/IV0.29
Discount 71%
Return to IV: +249.6%
Market implies -21.9%/yr
vs model +16.5% · below model
BAND
Deeply overvalued
Bandwidth Inc.
Price$53.27
Model IV$36.88
P/IV1.58
Premium +44%
Return to IV: -30.8%
Market implies +9.5%/yr
vs model +11.3% · in line
BANFP
Deeply undervalued
BANCFIRST CORP /OK/
Price$27.00
Model IV$81.24
P/IV0.33
Discount 67%
Return to IV: +200.9%
BBAI
Valuation N/A
BigBear.ai Holdings, Inc.
Price$2.39
Model IV—
P/IV—
Market implies +42.7%/yr
BBCP
Deeply overvalued
Concrete Pumping Holdings, Inc.
Price$9.36
Model IV$4.36
P/IV2.26
Premium +115%
Return to IV: -53.4%
Market implies +14.5%/yr
vs model +5.9% · above model
BBDC
Deeply undervalued
Barings BDC, Inc.
Price$8.52
Model IV$18.38
P/IV0.47
Discount 54%
Return to IV: +115.7%
Market implies -10.1%/yr
vs model +2.5% · below model
BBNX
Fairly valued
Beta Bionics, Inc.
Price$17.63
Model IV$18.23
P/IV1.04
Discount 3%
Return to IV: +3.4%
Market implies -2.9%/yr
vs model +50.0% · below model
BBOT
Valuation N/A
BridgeBio Oncology Therapeutics, Inc.
Price$3.31
Model IV—
P/IV—
Limited data — see page
BBSI
Deeply overvalued
BARRETT BUSINESS SERVICES INC
Price$31.72
Model IV$21.83
P/IV1.52
Premium +45%
Return to IV: -31.2%
Market implies +12.7%/yr
vs model +10.4% · in line
BBW
Deeply undervalued
BUILD-A-BEAR WORKSHOP INC
Price$25.53
Model IV$45.11
P/IV0.58
Discount 43%
Return to IV: +76.7%
Market implies -2.7%/yr
vs model +7.6% · below model
BCAL
Deeply overvalued
California BanCorp CA
Price$21.23
Model IV$14.44
P/IV1.49
Premium +47%
Return to IV: -32.0%
BCAT
Valuation N/A
BlackRock Capital Allocation Term Trust
Price$13.72
Model IV—
P/IV—
Limited data — see page
BCAX
Valuation N/A
Bicara Therapeutics Inc.
Price$17.50
Model IV—
P/IV—
Limited data — see page
BCML
Overvalued
BayCom Corp
Price$30.53
Model IV$25.11
P/IV1.24
Premium +22%
Return to IV: -17.8%
BCSF
Fairly valued
Bain Capital Specialty Finance, Inc.
Price$10.62
Model IV$11.82
P/IV0.95
Discount 10%
Return to IV: +11.3%
Market implies -0.2%/yr
vs model +2.8% · below model
BCX
Valuation N/A
BlackRock Resources & Commodities Strategy Trust
Price$12.16
Model IV—
P/IV—
Limited data — see page
BDJ
Valuation N/A
BlackRock Enhanced Equity Dividend Trust
Price$9.59
Model IV—
P/IV—
Limited data — see page
BDN
Deeply undervalued
BRANDYWINE REALTY TRUST
Price$2.68
Model IV$5.34
P/IV0.52
Discount 50%
Return to IV: +99.2%
BETA
Valuation N/A
BETA Technologies, Inc.
Price$20.98
Model IV—
P/IV—
Market implies +51.1%/yr
BFC
Deeply overvalued
Bank First Corp
Price$145.41
Model IV$71.41
P/IV2.14
Premium +104%
Return to IV: -50.9%
BFS
Fairly valued
SAUL CENTERS, INC.
Price$30.00
Model IV$26.99
P/IV1.12
Premium +11%
Return to IV: -10.0%
BFST
Fairly valued
Business First Bancshares, Inc.
Price$30.49
Model IV$30.54
P/IV0.95
Discount 0%
Return to IV: +0.2%
BGM
Valuation N/A
BGM Group Ltd.
Price$10.75
Model IV—
P/IV—
Market implies +79.3%/yr
BH
Undervalued
Biglari Holdings Inc.
Price$363.81
Model IV$469.58
P/IV0.77
Discount 23%
Return to IV: +29.1%
Market implies +0.6%/yr
vs model +6.2% · below model
BHB
Overvalued
BAR HARBOR BANKSHARES
Price$37.83
Model IV$31.90
P/IV1.26
Premium +19%
Return to IV: -15.7%
BHFAL
Deeply undervalued
Brighthouse Financial, Inc.
Price$15.05
Model IV$97.05
P/IV0.16
Discount 84%
Return to IV: +545.1%
BHFAM
Deeply undervalued
Brighthouse Financial, Inc.
Price$9.70
Model IV$97.05
P/IV0.10
Discount 90%
Return to IV: +900.6%
BHFAN
Deeply undervalued
Brighthouse Financial, Inc.
Price$10.94
Model IV$97.05
P/IV0.12
Discount 89%
Return to IV: +787.2%
BHFAO
Deeply undervalued
Brighthouse Financial, Inc.
Price$13.72
Model IV$97.05
P/IV0.14
Discount 86%
Return to IV: +607.4%